Neither ORP100S nor GM‐CSF interfered with the anti‐tumor activity of 5‐FU (Figure 5E,F), and both ORP100S and GM‐CSF showed comparable efficacy in reducing neutropenia (Figure 5G). This evidence concerns the gene CSF2 and neutropenia.